Articles related to PRODUCT RECALL

“The FDA said the reason for the recall is that the ‘product failed to meet dissolution acceptance criteria in the stability studies at the 6th month.'”

Nitrosamine impurities may increase cancer risk with long-term exposure above acceptable levels, though no immediate risk exists for patients currently taking this essential cardiovascular medication.

The presence of small stones in processed chocolate products highlights vulnerabilities in food manufacturing quality control systems, particularly in handling of natural ingredients like almonds.

Manufacturing deficiencies included inadequate contamination prevention and quality control measures, with historical context of previous recalls from the same facility that were associated with patient adverse events.

Unacceptable levels of N-nitroso atomoxetine, a potential carcinogen, were found in multiple atomoxetine batches, according to the FDA.

The FDA gave the recall a class 2 risk level, meaning that drinking the creamers ‘may cause temporary or medically reversible adverse health consequences,’ or that the possibility of serious health consequences is ‘remote.’